Matrix gla protein (MGP): An overexpressed and migration-promoting mesenchymal component in glioblastoma

BMC Cancer

Volumn 9, Issue , 2009, Pages 302-

  Mertsch, Sonja ^a   Schurgers, Leon J ^b   Weber, Kathrin ^a   Paulus, Werner ^a   Senner, Volker ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; MESSENGER RNA; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR BIOPSY; UPREGULATION; WOUND HEALING;

ADULT; AGED; BRAIN NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; UP-REGULATION;

EID: 70349873207     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-302     Document Type: Article

References (45)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114(2):97-109. 10.1007/s00401-007-0243-4, 1929165, 17618441.
2. Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007, 114(5):443-458. 10.1007/s00401-007-0293-7, 2039798, 17805551.
3. Giese A. Glioma invasion - pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1. Acta Neurochir Suppl 2003, 88:153-162.
4. Kleihues P. Glioblastoma. WHO Classification of Tumours of the Central Nervous System 2007, 33-49. Lyon: WHO, David N. Louis HO, Otmar D. Wistler, Webster K, 4.
5. McKeever PE. Insights about brain tumors gained through immunohistochemistry and in situ hybridization of nuclear and phenotypic markers. J Histochem Cytochem 1998, 46(5):585-594.
6. Paulus W, Huettner C, Tonn JC. Collagens, integrins and the mesenchymal drift in glioblastomas: a comparison of biopsy specimens, spheroid and early monolayer cultures. Int J Cancer 1994, 58(6):841-846. 10.1002/ijc.2910580616, 7523312.
7. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF. Gene expression profiling of gliomas strongly predicts survival. Cancer Res 2004, 64(18):6503-6510. 10.1158/0008-5472.CAN-04-0452, 15374961.
8. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006, 9(3):157-173. 10.1016/j.ccr.2006.02.019, 16530701.
9. Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 2006, 4(9):607-619. 10.1158/1541-7786.MCR-06-0005, 16966431.
10. Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003, 163(3):1033-1043. 1868272, 12937144.
11. Cancela L, Hsieh CL, Francke U, Price PA. Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene. J Biol Chem 1990, 265(25):15040-15048.
12. Chen L, O'Bryan JP, Smith HS, Liu E. Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization. Oncogene 1990, 5(9):1391-1395.
13. Chen Y, Miller C, Mosher R, Zhao X, Deeds J, Morrissey M, Bryant B, Yang D, Meyer R, Cronin F. Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res 2003, 63(8):1927-1935.
14. Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ. Coordinately up-regulated genes in ovarian cancer. Cancer Res 2001, 61(10):3869-3876.
15. Levedakou EN, Strohmeyer TG, Effert PJ, Liu ET. Expression of the matrix Gla protein in urogenital malignancies. Int J Cancer 1992, 52(4):534-537. 10.1002/ijc.2910520406, 1399132.
16. Micke P, Kappert K, Ohshima M, Sundquist C, Scheidl S, Lindahl P, Heldin CH, Botling J, Ponten F, Ostman A. In situ identification of genes regulated specifically in fibroblasts of human basal cell carcinoma. J Invest Dermatol 2007, 127(6):1516-1523. 10.1038/sj.jid.5700714, 17273163.
17. Price PA, Urist MR, Otawara Y. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983, 117(3):765-771. 10.1016/0006-291X(83)91663-7, 6607731.
18. Price PA, Williamson MK. Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. J Biol Chem 1985, 260(28):14971-14975.
19. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386(6620):78-81. 10.1038/386078a0, 9052783.
20. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 1999, 21(1):142-144. 10.1038/5102, 9916809.
21. Tatenhorst L, Senner V, Puttmann S, Paulus W. Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. J Neuropathol Exp Neurol 2004, 63(3):210-222.
22. Schurgers LJ, Teunissen KJ, Knapen MH, Geusens P, Heijde D, Kwaijtaal M, van Diest R, Ketteler M, Vermeer C. Characteristics and performance of an immunosorbent assay for human matrix Gla-protein. Clin Chim Acta 2005, 351(1-2):131-138. 10.1016/j.cccn.2004.08.003, 15563881.
23. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JP, Vermeer C. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005, 25(8):1629-1633. 10.1161/01.ATV.0000173313.46222.43, 15961706.
24. Goritz C, Thiebaut R, Tessier LH, Nieweg K, Moehle C, Buard I, Dupont JL, Schurgers LJ, Schmitz G, Pfrieger FW. Glia-induced neuronal differentiation by transcriptional regulation. Glia 2007, 55(11):1108-1122. 10.1002/glia.20531, 17582617.
25. Murshed M, Schinke T, McKee MD, Karsenty G. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004, 165(5):625-630. 10.1083/jcb.200402046, 2172384, 15184399.
26. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998, 18(9):1400-1407.
27. Schurgers LJ, Aebert H, Vermeer C, Bultmann B, Janzen J. Oral anticoagulant treatment: friend or foe in cardiovascular disease?. Blood 2004, 104(10):3231-3232. 10.1182/blood-2004-04-1277, 15265793.
28. Bostrom K, Zebboudj AF, Yao Y, Lin TS, Torres A. Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta1 activity in endothelial cells. J Biol Chem 2004, 279(51):52904-52913. 10.1074/jbc.M406868200, 15456771.
29. Fan C, Sheu D, Fan H, Hsu K, Allen Chang C, Chan E. Down-regulation of matrix Gla protein messenger RNA in human colorectal adenocarcinomas. Cancer Lett 2001, 165(1):63-69. 10.1016/S0304-3835(01)00416-5, 11248420.
30. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242(4885):1528-1534. 10.1126/science.3201241, 3201241.
31. Nishimoto SK, Nishimoto M. Matrix Gla protein C-terminal region binds to vitronectin. Co-localization suggests binding occurs during tissue development. Matrix Biol 2005, 24(5):353-361. 10.1016/j.matbio.2005.05.004, 15982861.
32. Zebboudj AF, Imura M, Bostrom K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 2002, 277(6):4388-4394. 10.1074/jbc.M109683200, 11741887.
33. Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008, 13(1):69-80. 10.1016/j.ccr.2007.12.005, 18167341.
34. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, Vescovi AL. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006, 444(7120):761-765. 10.1038/nature05349, 17151667.
35. Canoll P, Goldman JE. The interface between glial progenitors and gliomas. Acta Neuropathol 2008, 116(5):465-77. 10.1007/s00401-008-0432-9, 18784926.
36. Dufourcq P, Louis H, Moreau C, Daret D, Boisseau MR, Lamaziere JM, Bonnet J. Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol 1998, 18(2):168-176.
37. Jang YC, Tsou R, Gibran NS, Isik FF. Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice. Surgery 2000, 127(6):696-704. 10.1067/msy.2000.105858, 10840366.
38. Podor TJ, Peterson CB, Lawrence DA, Stefansson S, Shaughnessy SG, Foulon DM, Butcher M, Weitz JI. Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin. J Biol Chem 2000, 275(26):19788-19794. 10.1074/jbc.M908079199, 10764803.
39. Zheng X, Saunders TL, Camper SA, Samuelson LC, Ginsburg D. Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci USA 1995, 92(26):12426-12430. 10.1073/pnas.92.26.12426, 40370, 8618914.
40. Gladson CL, Cheresh DA. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 1991, 88(6):1924-1932. 10.1172/JCI115516, 295768, 1721625.
41. Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin Cancer Res 1999, 5(6):1587-1594.
42. Gladson CL, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Sci 1995, 108(Pt 3):947-956.
43. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 2004, 36(6):1046-1069. 10.1016/j.biocel.2004.01.013, 15094120.
44. Hu B, Kong LL, Matthews RT, Viapiano MS. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J Biol Chem 2008, 283(36):24848-24859. 10.1074/jbc.M801433200, 18611854.
45. Aguiar CB, Lobao-Soares B, Alvarez-Silva M, Trentin AG. Glycosaminoglycans modulate C6 glioma cell adhesion to extracellular matrix components and alter cell proliferation and cell migration. BMC Cell Biol 2005, 6:31. 10.1186/1471-2121-6-31, 1201133, 16111491.